British Columbia Investment Management’s Legend Biotech LEGN Stock Holding History

British Columbia Investment Management’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$826K	Hold	28,600	–	–	0.01%	655
2026 Q1	$517K	Hold	28,600	–	–	﹤0.01%	689
2025 Q4	$622K	Hold	28,600	–	–	﹤0.01%	687
2025 Q3	$933K	Buy	28,600 +3,600	+14%	+$133K	0.01%	664
2025 Q2	$887K	Sell	25,000 -3,800	-13%	-$123K	0.01%	660
2025 Q1	$977K	Hold	28,800	–	–	0.01%	682
2024 Q4	$937K	Hold	28,800	–	–	0.01%	697
2024 Q3	$1.4M	Hold	28,800	–	–	0.01%	670
2024 Q2	$1.28M	Hold	28,800	–	–	0.01%	682
2024 Q1	$1.62M	Hold	28,800	–	–	0.01%	614
2023 Q4	$1.73M	Buy	28,800 +5,200	+22%	+$330K	0.01%	577
2023 Q3	$1.59M	Buy	23,600 +500	+2%	+$34.7K	0.02%	492
2023 Q2	$1.59M	Sell	23,100 -700	-3%	-$45.7K	0.01%	514
2023 Q1	$1.15M	Buy	23,800 +4,000	+20%	+$196K	0.01%	605
2022 Q4	$988K	Hold	19,800	–	–	0.01%	628
2022 Q3	$808K	Buy	19,800 +900	+5%	+$42.2K	0.01%	694
2022 Q2	$1.04M	Hold	18,900	–	–	0.01%	689
2022 Q1	$687K	Hold	18,900	–	–	﹤0.01%	806
2021 Q4	$881K	Buy	+18,900	New	+$959K	0.01%	799

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

British Columbia Investment Management's LEGN Position: Q2 2026 in Review

British Columbia Investment Management held its Legend Biotech (LEGN) position steady in Q2 2026 at 28,600 shares worth $826K. The position accounts for 0.01% of the portfolio, ranked #655.

British Columbia Investment Management first reported a position in LEGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.73M in Q4 2023. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

British Columbia Investment Management held 28,600 shares of Legend Biotech worth $826K as of Q2 2026.
British Columbia Investment Management left its Legend Biotech share count unchanged in Q2 2026.
Legend Biotech made up 0.01% of British Columbia Investment Management's portfolio in Q2 2026, its #655 holding.
British Columbia Investment Management first reported a position in Legend Biotech in Q4 2021 and has held it in 19 quarters since.
British Columbia Investment Management's Legend Biotech position peaked at $1.73M in Q4 2023.
219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on British Columbia Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.